ANN ARBOR, Mich. (AP) — Esperion Therapeutics Inc. (ESPR) on Tuesday reported a loss of $104.5 million in its fourth quarter.

On a per-share basis, the Ann Arbor, Michigan-based company said it had a loss of $3.89.

Copyright by Automated Insights, Inc. All rights reserved.